Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 41 (1) , 82-90
- https://doi.org/10.1016/j.jvs.2004.10.029
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 proteinThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial IschemiaCirculation, 2002
- Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina PectorisCirculation, 2002
- Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazardsCardiovascular Research, 2001
- VEGF gene therapy: stimulating angiogenesis or angioma-genesis?Nature Medicine, 2000
- Vascular-specific growth factors and blood vessel formationNature, 2000
- Clinical Trials in Coronary Angiogenesis: Issues, Problems, ConsensusCirculation, 2000
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic LesionsCirculation, 1998
- Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb IschemiaCirculation, 1998